4-(4-Piperidin-1-yl-butoxy)-phenylamine → HCID 178418885, 화합물
반응식
[N:1]1([CH2:7][CH2:8][CH2:9][CH2:10][O:11][C:12]2[CH:17]=[CH:16][C:15]([NH2:18])=[CH:14][CH:13]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[F:19][C:20]1[CH:28]=[C:27]2[C:23]([C:24](=[CH:30]O)[C:25](=[O:29])[NH:26]2)=[CH:22][CH:21]=1>>[F:19][C:20]1[CH:28]=[C:27]2[C:23]([C:24](=[CH:30][NH:18][C:15]3[CH:14]=[CH:13][C:12]([O:11][CH2:10][CH2:9][CH2:8][CH2:7][N:1]4[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]4)=[CH:17][CH:16]=3)[C:25](=[O:29])[NH:26]2)=[CH:22][CH:21]=1참가 물질
3
실험 절차
In a manner similar to that described in Example 231, 4-(4-piperidin-1-yl-butoxy)-phenylamine (400 mg, 1.1 equiv.) and 6-fluoro-3-hydroxymethylene-1,3-dihydro-indol-2-one (263 mg, 1.47 mmol, 1 equiv.) are reacted to give the named compound as a yellow solid (435 mg, 73%).
후처리
- customare reacted
출처 및 근거
- ORD 기록
- ord-bd36ddb1ba5c4fc28ef4bc92558c279d
- 출처 데이터셋
- uspto-grants-2006_08
- DOI